Latest update:
Tuesday, May 10, 2016 - 14:46
The Board of Directors of Sopharma AD (the “Company”) notifies that for February 2013 Sopharma AD realized an increase of sales revenues of 6% compared to the same period of 2012, including 2% decrease of domestic sales and 8% increase of export sales.
During the past two months Sopharma AD recorded a decrease of sales revenues of 2%, including 2% decrease of export sales and same level of domestic sales compared to 2012.